Report Id: PWDDM0423
Wilson Disease Drugs Market by Drug Type (Trientine, Zinc and Penicillamine), Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2023 - 2028
The Wilson Disease Drugs Market is projected to grow at a rate of 4.2% CAGR by 2028.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- ANI Pharmaceuticals Inc
- Lupin Ltd
- Teva Pharmaceutical Industries Limited
- Dr.Reddy's Laboratories Ltd
- Bausch Health Companies Inc
Study period:
Fastest Growing Market:
2023 - 2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
4
REPORT DESCRIPTION
Wilson’s disease (WD) is a genetic disease wherein defective biliary elimination of copper results in the accumulation, especially in the liver and brain. The disease is persistent and, if left untreated, may lead to liver (hepatic) disease, central nervous system dysfunction, and death. Early diagnosis and treatment may avoid serious long-term disability and life-threatening complications. The characteristics of this disorder are a combination of liver disease and neurological and psychiatric problems. The key factors leading to revenue growth of the Wilson disease market are diseases increasing incidence, the pharmaceutical industry and research organizations have been forced to emphasize on the discovery of a treatment for Wilson disease. Majorly boosting industrial growth are leading competitor’s ongoing research initiatives and the adoption of innovative technology in Wilson’s disease drugs market. But, the factors such as negative impacts of the Wilson disease drugs will hamper the Wilson’s disease drugs market growth. The Wilson Disease Drugs Market is projected to grow at a rate of 4.2% CAGR by 2028.
The Wilson Disease Drugs Market has been segmented as below:
Wilson Disease Drugs Market on the basis of Drug Type
- Trientine
- Zinc
- Penicillamine
Wilson Disease Drugs Market on the basis of Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Wilson Disease Drugs Market on the basis of Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
On the basis of drug type the, Wilson disease drugs market is majorly segregated into Trientine, Zinc and Penicillamine. Among them the Penicillamine segment is likely to hold the significant share in the market. This can be ascribed to the surge in Wilson disease occurrence and the pharmaceutical industry and research organizations have been forced to emphasize on the discovery of a treatment for Wilson disease. In addition to this, the key players' ongoing research initiatives and the deployment of innovative technology in this market as well as high government and private sector funding in the Wilson disease research which further fuel the market growth.
Further based on the distribution channel, the market is classified into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. The Retail Pharmacies segment is having highest share in the Wilson disease drugs market. This is owing to the surge in Wilson disease patients, the surging number of independent pharmacies and chains coupled with the availability of medications in supermarkets & mass retailers Moreover, the swift adoption of automation technologies, such as dispensing, pharmacy robots, and packaging systems is propelling the segment growth.
Accordance to the regional analysis, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America has the significant contribution the market growth due to the investments made by the leading players for several R&D activities as well as launch of new products in the U.S. Apart from this, rise in the awareness among the consumers for the adoption of Wilson disease drugs further boost the market growth.
Most of the people are visiting clinics with complaints of abdominal pain, anxiety and depression, dark urine or light stool color, mood changes, jaundice, disruptive thoughts and feelings, rings around the outline of the patient's cornea, quivers, and stiff muscles. Wilson’s disease shows all of these symptoms. Additionally, the retail pharmacy demand for Trientine, Penicillamine, and Zinc drugs has surged by 48%. Above mentioned factors is augmenting demand for the global Wilson disease drugs market and are projected to grow during the forecast period.
The major competitors included in the ambulatory healthcare services market report are ANI Pharmaceuticals Inc, Teva Pharmaceutical Industries Limited, Lupin Ltd, Dr.Reddy's Laboratories Ltd, Bausch Health Companies Inc., Panacea Biotec Ltd, Par pharmaceutical, Navinta llc,, Breckenridge pharmaceutical, inc. and Valeant Pharmaceuticals International, Inc.
Wilson’s disease is a genetic disease and is a very dreadful disease hence, an untreated patient live up to 40 years. Henceforth, the demand for Wilson’s disease drugs has a huge demand among the patients. Also, there has a significant demand for drugs from healthcare workers.
- This report analysis assists players in the market to know the present trends, dynamics and opportunities of the market and requirements of the end users.
- The competitive analysis of the key competitors mentioned in the report, allow users to perceive the dynamic strategies such as technology innovation, partnerships, merger & acquisitions and joint ventures of the key competitors
- This report also includes the SWOT analysis, portfolio analysis, capability analysis of the leading competitors
- Quantitative analysis of the market allows users to understand the factual of the market across four major regions
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Drug Type: Market Size & Analysis
5.1. Overview
5.2. Trientine
5.3. Zinc
5.4. Penicillamine
6. Distribution Channel: Market Size & Analysis
6.1. Overview
6.2. Retail Pharmacies
6.3. Hospital Pharmacies
6.4. Online Pharmacies
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. ANI Pharmaceuticals Inc
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Teva Pharmaceutical Industries Limited
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Lupin Ltd
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Dr.Reddy's Laboratories Ltd
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Bausch Health Companies Inc.
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Panacea Biotec Ltd
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Par pharmaceutical
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Navinta llc
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Breckenridge pharmaceutical, inc.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Valeant Pharmaceuticals International, Inc
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
The Wilson Disease Drugs Market has been segmented as below:
Wilson Disease Drugs Market on the basis of Drug Type
- Trientine
- Zinc
- Penicillamine
Wilson Disease Drugs Market on the basis of Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Wilson Disease Drugs Market on the basis of Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Wilson Disease Drugs Market?
The market is expected to grow at a CAGR of 5% during the study period (2023-2028)
What is the segment’s covered for the Wilson Disease Drugs Market?
The segment included in Seed Treatment Market is Drug Type,Distribution Channel and region.
Who are the major key vendors in the Wilson Disease Drugs Market?
Some key players operating in the Wilson Disease Drugs Market include ANI Pharmaceuticals Inc, Teva Pharmaceutical Industries Limited, Lupin Ltd, Dr.Reddy's Laboratories Ltd
What are the different forms of the report available?
We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE